Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

9.5K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Antimicrobial Proteins01:23

Antimicrobial Proteins

985
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
985
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Dynamic NMR Lineshape Simulation Framework for Lipid Diffusion and Membrane Thinning in Bicelles and Nanodiscs.

The journal of physical chemistry. B·2026
Same author

Molecular Mechanisms Governing Peptide Nanodisc Assembly and Stability.

bioRxiv : the preprint server for biology·2026
Same author

Gangliosides GM3 And GD3 Modulate Insulin Aggregation Pathways and Reduce Cytotoxicity Through Structural Remodeling.

bioRxiv : the preprint server for biology·2026
Same author

A two-stage inverse intelligent path optimization model for human-water relationship regulation.

Water research·2025
Same author

PRIME: a database for 16S rRNA microbiome data with phenotypic reference and comprehensive metadata.

Nucleic acids research·2025
Same author

Structures, Interactions, and Antimicrobial Activity of the Shortest Thanatin Peptide from <i>Anasa tristis</i>.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Jun 29, 2025

A11-positive &#946;-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

11.9K

LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases.

Surajit Bhattacharjya1, Zhizhuo Zhang2, Ayyalusamy Ramamoorthy2,3

  • 1School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore.

Biomolecules
|March 28, 2024
PubMed
Summary
This summary is machine-generated.

Antimicrobial peptides (AMPs), such as LL37, are crucial for innate immunity against pathogens and antibiotic-resistant bacteria. This review explores LL37

Keywords:
LL37antimicrobial peptidesbiophysicalhost defense peptideshuman antimicrobial peptidesstructure

More Related Videos

Preparation of Oligomeric &#946;-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

23.2K
Rapid Generation of Amyloid from Native Proteins In vitro
05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

6.2K

Related Experiment Videos

Last Updated: Jun 29, 2025

A11-positive &#946;-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

11.9K
Preparation of Oligomeric &#946;-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

23.2K
Rapid Generation of Amyloid from Native Proteins In vitro
05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

6.2K

Area of Science:

  • Innate immunity and host defense mechanisms.
  • Antimicrobial peptide research.
  • Drug discovery and development.

Background:

  • Antimicrobial peptides (AMPs) and host defense peptides (HDPs) are vital components of the innate immune system.
  • Human AMPs include defensins, histatins, and cathelicidins like LL37.
  • The rise of multi-drug resistant bacteria necessitates novel antimicrobial strategies.

Purpose of the Study:

  • To provide an integrative, mechanistic insight into LL37 and its derived peptides.
  • To consolidate recent biophysical, structural, and functional studies on LL37.
  • To guide future research on LL37-based molecule design.

Main Methods:

  • Review of existing literature on LL37.
  • Analysis of biophysical and structural studies.
  • Functional assessment of LL37's host defense activities.

Main Results:

  • LL37 is a key human cathelicidin with broad-spectrum antimicrobial activity.
  • LL37 exhibits diverse functions beyond direct pathogen killing, including immunomodulation and wound healing.
  • LL37 also demonstrates anti-cancer and anti-amyloidogenic properties.

Conclusions:

  • LL37 is a promising candidate for developing new antimicrobial agents against resistant pathogens.
  • Understanding LL37's multifaceted activities is crucial for therapeutic applications.
  • Further research into LL37 structure-activity relationships will enable novel therapeutic designs.